Health Care

Washington, D.C.—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, applauded Senate passage of H.R. 3204, the Drug Quality and Security Act, a bipartisan bill that would improve consumer drug safety. The bill included several provisions, with minor modifications, from legislation Cummings introduced, The Gray Market Drug Reform and Transparency Act of 2013 (H.R. 1958).

Washington, D.C.—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement regarding the Committee's upcoming field hearings on the Affordable Care Actin North Carolina, Georgia, Texas, and Arizona:

Washington, D.C.—Today, Rep. Elijah E.

Washington, D.C. (Nov. 11, 2013)—Today, Reps. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, and Gerald E. Connolly, Ranking Member of the Subcommittee on Government Operations, sent a letter to Chairman Darrell Issa requesting that he withdraw the unilateral subpoena he issued last week to compel U.S.

Washington, D.C.—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, sent a letter to Chairman Darrell Issa citingevidence obtained by the Committee a full week ago that directly contradicts Issa's unfounded accusations that U.S.

Washington, D.C.—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, and Rep. Gerald E.

Washington, DC—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, sent a letter to Committee Chairman Darrell E.